SynCore Biotechnology Co.,Ltd (TPEX:4192)
Taiwan · Delayed Price · Currency is TWD 19.85
+0.30 (1.53%)
At close: Apr 24, 2026
TPEX:4192 Revenue
In the year 2025, SynCore Biotechnology Co.,Ltd had annual revenue of 27.04M TWD with 15.88% growth. SynCore Biotechnology Co.,Ltd had revenue of 7.37M in the quarter ending December 31, 2025, with 11.93% growth.
Revenue
27.04M
Revenue Growth
+15.88%
P/S Ratio
25.81
Revenue / Employee
676.08K
Employees
40
Market Cap
698.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.04M | 3.71M | 15.88% |
| Dec 31, 2024 | 23.34M | 3.14M | 15.55% |
| Dec 31, 2023 | 20.20M | 4.34M | 27.36% |
| Dec 31, 2022 | 15.86M | 8.92M | 128.52% |
| Dec 31, 2021 | 6.94M | -6.40M | -47.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Level Biotechnology | 736.59M |
| Taiwan Advance Bio-Pharmaceutical | 371.86M |
| TCI GENE | 273.61M |
| BioLASCO Taiwan | 262.66M |
| Lukas Biomedical | 180.32M |
| NatureWise Biotech & Medicals | 180.29M |
| Visgeneer | 159.76M |
| Vectorite Biomedical | 67.90M |